Improving medication adherence for cancer patients through coaching
Design and implementation of a social cognitive theory-based medication adherence coaching intervention
['FUNDING_CAREER'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-10899647
This study is all about helping cancer patients stick to their medication plans by providing personalized coaching and support, so they can overcome challenges and feel more confident in their treatment.
Quick facts
| Phase | ['FUNDING_CAREER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-10899647 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a coaching intervention based on social cognitive theory to help cancer patients adhere to their medication regimens. It aims to identify and address barriers to adherence, such as lack of social support and self-efficacy, which are often overlooked in traditional approaches. By implementing a structured plan and utilizing expert mentorship, the project seeks to create a sustainable program that enhances patient outcomes in cancer treatment. Patients will receive tailored support to improve their medication-taking behaviors, ultimately aiming for better health results.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who are prescribed oral anticancer agents and struggle with medication adherence.
Not a fit: Patients who are not undergoing treatment with oral anticancer agents or those who have no adherence issues may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve medication adherence among cancer patients, leading to better treatment outcomes and quality of life.
How similar studies have performed: Previous research has shown that theory-guided interventions can effectively improve medication adherence in various patient populations, suggesting a promising approach for this study.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MULUNEH, BENYAM — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: MULUNEH, BENYAM
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Anti-Cancer Agents